|
|||||
|
|
ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63 |
|
| Authors: | Alba Torres Mohammed Alshalalfa Elai Davicioni Anuj Gupta Srinivasan Yegnasubramanian Sarah J. Wheelan Jonathan I. Epstein Angelo M. De Marzo Tamara L. Lotan MD |
| Affiliation: | 1. Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland;2. GenomeDx Biosciences, Vancouver, British Columbia;3. Department of Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland;4. Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland;5. Department of Urology, Johns Hopkins School of Medicine, Baltimore, Maryland |
| Abstract: | |
| Keywords: | ETS2 gene expression in situ hybridization p63 prostate basal cells prostatic carcinoma |